Wysa Just Got £5.3M for India—Why US Consumers Need Something Different

Big news in the AI mental health space: Wysa just secured £5.3 million to expand mental health services in rural India. The grant focuses on integrating AI support into India's healthcare system.

This is genuinely good news for global mental health access. India has a massive mental health gap—millions of people with limited access to support.

But here's what the headlines don't say: this move signals exactly where Wysa's focus is heading. And if you're a US consumer looking for AI mental health support, it's not toward you.

What Wysa Is Actually Building

Let's break down what this funding means:

• B2B healthcare partnerships. Wysa is integrating with health systems, not building for individual consumers.
• Enterprise focus. Their business model increasingly relies on corporate wellness contracts and institutional partnerships.
• International expansion. India, UK NHS contracts, global health organizations. The US consumer market isn't the priority.

This is a legitimate business strategy. Enterprise contracts are more stable than consumer subscriptions. Healthcare partnerships provide scale.

But it leaves a gap.

The US Consumer Gap

If you're in the US and looking for AI mental health support, here's your current landscape:

• Woebot — Shut down in 2025
• Wysa — Pivoting to enterprise/international
• Calm/Headspace — Meditation-focused, not conversational AI
• Replika — Companionship-focused, not mental health-focused
• ChatGPT — General purpose, no mental health specialization

The "consumer AI therapy app designed for US users" category is surprisingly thin.

What US Consumers Actually Need

Based on user research and reviews, here's what American users are looking for—and not finding:

1. Voice-First Interaction

US users increasingly want to talk, not type. Late-night anxiety doesn't lend itself to keyboard interaction.

2. Memory and Continuity

Americans are frustrated with AI that forgets them. "I've told Wysa about my work stress 100 times" is a common complaint.

3. Cultural Context

US-specific stressors: healthcare costs, work culture, student loans, social dynamics. Apps built for global markets can feel generic.

4. Consumer-First Design

Enterprise products optimize for institutional buyers. Consumer products optimize for user experience. These aren't the same thing.

Why This Matters

The shift isn't good or bad—it's a market evolution. Companies are following the money to enterprise contracts and international expansion.

But it creates an opportunity gap in the US consumer market.

Millions of Americans want AI mental health support. They're not getting it through their employer's wellness program. They're not covered by NHS-style healthcare. They're looking for something they can download and use tonight.

What to Look For Instead

If you're a US consumer evaluating AI mental health apps in 2026, prioritize:

• Consumer-first business model. Are they building for you, or are you a side effect of their enterprise strategy?
• US-based development. Cultural context matters for mental health support.
• Feature focus on individual needs. Memory, voice, personalization—not enterprise dashboards and compliance features.
• Active development. Is the app improving monthly, or is it in maintenance mode while the company focuses elsewhere?

The Bottom Line

Wysa's India expansion is good for global mental health access. Full stop.

But if you're in the US looking for AI mental health support, recognize that you're not their target user anymore. The companies that dominated this space are either gone (Woebot) or pivoting away from you (Wysa).

The good news: new players are emerging to fill the gap. The consumer AI therapy space is wide open.

Stella is built specifically for US consumers who want voice-first, memory-enabled AI support. Join the waitlist.